APLM
Apollomics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$27.50
−1.84%Margins
Gross margin
100.0%
EBITDA margin
-580.9%
EBIT margin
-593.3%
Net margin
-745.0%
FCF margin
-119.2%
2032.5%
Return on equity
-965.1%
Return on assets
2027.9%
Return on invested capital
0.98x
Asset turnover
-$10.4M
Cash from operations
$1.13
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025